Delivery Order SPE2DB22D1106-SPE2DB25FDZU6
Award Date
2/21/25
Potential Completion Date
2/24/25
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,971.45 firm fixed-price delivery order is for the supply of NALBUPHINE 100 MG/10 ML VIAL 10ML, a pharmaceutical product. The contract has a completion date of February 4, 2025 and was awarded on February 3, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, with a ceiling value of $1,270.82, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order and has a Firm Fixed Price pricing type, with an ultimate completion date of February 24, 2025. The contract is for the supply of NALBUPHINE 100 MG/10 ML VIAL 10ML, a pharmaceutical product. This award is not designated as a set-aside contract....
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order valued at $2,036.86 for the supply of NALBUPHINE 100 MG/10 ML VIAL 10ML. The award was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on February 18, 2025, with a completion date of February 19, 2025. This contract represents a small portion of Amerisourcebergen's broader contracting relationship with the federal government, as the company...
This federal contract award, valued at $4,237.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567286025 - NALBUPHINE 100 MG/10 ML VIAL 10ML, a pharmaceutical product, with a period of performance through February 18, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued...
This federal contract award, identified as SPE2DX15D6028|Q166, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract, a Delivery Order valued at $76,909.82, is for the supply of 4539048107 - NALBUPHINE 10ML 25S, a pharmaceutical product. The contract is a Firm Fixed Price arrangement without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office division, involves the delivery of NALBUPHINE 200 MG/10 ML VIAL 10ML pharmaceutical products. The award, valued at $4,561.80, was made by the Defense Logistics Agency (DLA) on August 14, 2024, with a completion date of August 15, 2024. This is a Firm Fixed Price Delivery Order contract, and there is no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal...
This contract award is for the delivery of NALBUPHINE 200 MG/10 ML VIAL 10ML to the Defense Logistics Agency (DLA). The contract, valued at $3,506.79, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider registered in the System for Award Management (SAM.gov). The contract has a ceiling value of $3,506.79 and is a Firm Fixed Price Delivery Order with a final completion date of January 31, 2025. The contract is not...
The federal contract award is for the delivery of Nalbuphine 100 mg/10 ml vials to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $1,473.54 and an ultimate completion date of December 29, 2023. This award is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,121.49 firm fixed-price delivery order is for pre-filled ampules of 0.25 ml and has an ultimate completion date of August 16, 2024. This award is not designated as a set-aside contract. The contract is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop...
This federal contract award from the Defense Logistics Agency (DLA) is a Delivery Order valued at $1,583.25 issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the supply of various medical products including syringes, fluids, and medications across multiple therapeutic areas such as cardiovascular health, diabetes management, mental health, pain management, and infectious disease prevention. The award is part of a...